Day two of the J.P Morgan Healthcare Conference rolled on with positive data from Sling Therapeutics Inc. that is leading the company to a phase III study in treating thyroid eye disease. The ...
High-yield dividend stocks may not appeal to some investors. However, if you're among those investors looking for income, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback